| Unlike bisphosphonates, the therapeutic effect of denosumab can be assessed using radial dual-energy X-ray absorptiometry (radial DXA) in clinics. |
| Radial DXA revealed the efficacy of denosumab in rheumatoid arthritis (RA) and RA + glucocorticoid groups that responded poorly to bisphosphonate treatment. |
| Adherence to denosumab treatment was significantly higher than that for bisphosphonate treatment. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.